Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.40 |
| ▸ | PCNA | P12004 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19182412 | 0.88 | PARP1 (0.43) | PARP1ALDH1A1GAAGFERNUDT1 | |
| SCHEMBL10665217 | 0.86 | PARP1 (0.46) | PARP1ALDH1A1GAAGFERNUDT1 | |
| SCHEMBL10175368 | 0.83 | PARP1 (0.43) | PARP1NUDT1PCNAHDAC4HDAC6 | |
| SCHEMBL28229854 | 0.80 | PARP1 (0.42) | PARP1ALDH1A1GAAGFERNUDT1 | |
| SCHEMBL5094928 | 0.79 | GAA (0.53) | PARP1ALDH1A1GAAGFERNUDT1 | |
| SCHEMBL19180433 | 0.79 | SKP2 (0.46) | PARP1ALDH1A1GAAGFERNUDT1 | |
| SCHEMBL18772546 | 0.79 | PRKCI (0.49) | PARP1ALDH1A1GAAGFERNUDT1 | |
| SCHEMBL19181011 | 0.78 | PARP1 (0.43) | PARP1ALDH1A1GAAGFERNUDT1 | |
| SCHEMBL5100488 | 0.78 | ALDH1A1 (0.51) | ALDH1A1GAAGFERCHEK1 | |
| SCHEMBL19180323 | 0.78 | CYP3A4 (0.52) | PARP1NUDT1CHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6368573-B1 | MEASURING MYOCARDIAL FUNCTION IN MAMMAL | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. | 2002-04-09 | — | — | US | disclosed |
| US-5063233-A | Cardiovascular disorders | CIBA-GEIGY CORPORATION (US) | 1991-11-05 | — | — | US | disclosed |
| US-5034381-A | Antagonist | CIBA-GEIGY CORPORATION (US) | 1991-07-23 | — | — | US | disclosed |
| US-4968697-A | ADENOSINE-2 RECEPTOR AGONISTS | CIBA-GEIGY CORPORATION (US) | 1990-11-06 | — | — | US | disclosed |
| US-4954504-A | Hypotensive agents, psychotic disorders | CIBA-GEIGY CORPORATION (US) | 1990-09-04 | — | — | US | disclosed |
| EP-0323807-A2 | Certain 2-substituted adenosine derivatives | CIBA-GEIGY AG (CH) | 1989-07-12 | — | — | EP | disclosed |
| EP-0277917-A2 | Certain adenosine 5'-carboxamide derivatives | CIBA-GEIGY AG (CH) | 1988-08-10 | — | — | EP | disclosed |
| EP-0267878-A1 | N9-cyclopentyl-substituted adenine derivatives | CIBA-GEIGY AG (CH) | 1988-05-18 | — | — | EP | disclosed |